These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 16011814)

  • 1. Canadian guidelines for the management of benign prostatic hyperplasia.
    Nickel JC; Herschorn S; Corcos J; Donnelly B; Drover D; Elhilali M; Goldenberg L; Grantmyre J; Laroche B; Norman R; Piercy B; Psooy K; Steinhoff G; Trachtenberg J; Saad F; Tanguay S; ;
    Can J Urol; 2005 Jun; 12(3):2677-83. PubMed ID: 16011814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The American Urological Association 2003 guideline on management of benign prostatic hyperplasia: a Canadian opinion.
    Nickel JC; Saad F
    Can J Urol; 2004 Apr; 11(2):2186-93. PubMed ID: 15182407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).
    Madersbacher S; Alivizatos G; Nordling J; Sanz CR; Emberton M; de la Rosette JJ
    Eur Urol; 2004 Nov; 46(5):547-54. PubMed ID: 15474261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of lower urinary tract symptoms secondary to benign prostatic hyperplasia with open prostatectomy: results of a contemporary series.
    Helfand B; Mouli S; Dedhia R; McVary KT
    J Urol; 2006 Dec; 176(6 Pt 1):2557-61; discussion 2561. PubMed ID: 17085158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Benign prostatic hyperplasia. Guidelines and recommendations in urological clinical practice].
    Silva MM; Sousa RC
    Acta Med Port; 1999; 12(1-3):103-11. PubMed ID: 10423883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign prostatic hyperplasia evaluation and management by urologists and primary care physicians: practice patterns from the observational BPH registry.
    Wei JT; Miner MM; Steers WD; Rosen RC; Seftel AD; Pasta DJ; Carman WJ; Roehrborn CG;
    J Urol; 2011 Sep; 186(3):971-6. PubMed ID: 21791352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outline of JUA clinical guidelines for benign prostatic hyperplasia.
    Homma Y; Gotoh M; Yokoyama O; Masumori N; Kawauchi A; Yamanishi T; Ishizuka O; Seki N; Kamoto T; Nagai A; Ozono S;
    Int J Urol; 2011 Nov; 18(11):741-56. PubMed ID: 22050351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign prostatic hyperplasia: a review.
    Ramsey EW
    Can J Urol; 2000 Dec; 7(6):1135-43. PubMed ID: 11151094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
    Fourcade RO; Théret N; Taïeb C;
    BJU Int; 2008 May; 101(9):1111-8. PubMed ID: 18279447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canadian Urological Association guidelines on urinary incontinence.
    Corcos J; Gajewski J; Heritz D; Patrick A; Reid I; Schick E; Stothers L;
    Can J Urol; 2006 Jun; 13(3):3127-38. PubMed ID: 16813704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice patterns among primary care physicians in benign prostatic hyperplasia and prostate cancer.
    Fawzy A; Fontenot C; Guthrie R; Baudier MM
    Fam Med; 1997 May; 29(5):321-5. PubMed ID: 9165283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of benign prostatic hyperplasia.
    Barry M; Roehrborn C
    Annu Rev Med; 1997; 48():177-89. PubMed ID: 9046954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research.
    McConnell JD; Barry MJ; Bruskewitz RC
    Clin Pract Guidel Quick Ref Guide Clin; 1994 Feb; (8):1-17. PubMed ID: 7507389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of benign prostatic hyperplasia.
    Edwards JL
    Am Fam Physician; 2008 May; 77(10):1403-10. PubMed ID: 18533373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing benign prostatic hyperplasia in primary care. Patient-centred approach.
    McSherry J; Weiss R
    Can Fam Physician; 2000 Feb; 46():383-9. PubMed ID: 10690495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definition of at-risk patients: dynamic variables.
    Emberton M
    BJU Int; 2006 Apr; 97 Suppl 2():12-5; discussion 21-2. PubMed ID: 16507047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BPH: new guidelines based on symptoms and patient preference. The Agency for Health Care Policy and Research.
    Roberts RG
    Geriatrics; 1994 Jul; 49(7):24-31. PubMed ID: 7517377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.